A Phase 3 Randomized, Double-Blind, non-Inferiority Trial Evaluating Isavuconazole (ISA) vs. Voriconazole (VRC) for the Primary Treatment of Invasive Fungal Disease (IFD) Caused by Aspergillus spp. or Other Filamentous Fungi (SECURE): Outcomes by Malignancy Status - Ullman, A J; Shoham, S; Huang, W (2014)
54th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC;